Eli Samaha

Eli Samaha

Board Member · Stagwell Inc

Rank #1,508 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardBusiness & Professional ServicesSTGWSEC CIK 0001877589

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$71.5M
1-day change
▼ 1.46%
Positions on file
3
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$37.8M – $74.8M2026-09-04

Insider activity May 1, 2024 – Jan 2, 2026

Eli Samaha is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 22 transactions between May 1, 2024 and Jan 2, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$24.75M
6 purchases on file priced rows only
Open-market sales (code S)
$10.05M
7 sales on file priced rows only
All reported transactions
22
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

5 insiders bought Stagwell Inc (STGW) shares worth $4,058,588 between May 9, 2025 and Jun 5, 2025

Cluster buying

5 different insiders made 8 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Stagwell Inc (STGW) shares worth $4,058,588 between May 9, 2025 and Jun 5, 2025
Date Insider Transaction Shares Price Value Filing
May 9, 2025 Mark Jeffery Penn P Open-market purchase 10,000 held after: 9,004,055 $4.74 $47,400 SEC filing ↗
May 9, 2025 Eli Samaha P Open-market purchase 200,903 held after: 7,348,565 $4.76 $956,298 SEC filing ↗
May 21, 2025 Desiree G. Rogers P Open-market purchase 2,086 held after: 162,014 $4.75 $9,909 SEC filing ↗
May 21, 2025 Mark Jeffery Penn P Open-market purchase 10,000 held after: 9,014,055 $4.87 $48,700 SEC filing ↗
Jun 3, 2025 Jay Leveton P Open-market purchase 2,500 held after: 2,693,720 $4.06 $10,150 SEC filing ↗
Jun 4, 2025 Charlene Barshefsky P Open-market purchase 24,350 held after: 185,316 $4.31 $104,949 SEC filing ↗
Jun 4, 2025 Eli Samaha P Open-market purchase 425,757 held after: 7,774,322 $4.27 $1,817,982 SEC filing ↗
Jun 5, 2025 Eli Samaha P Open-market purchase 240,000 held after: 8,014,322 $4.43 $1,063,200 SEC filing ↗

Total of the rows above: $4,058,588, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Eli Samaha bought 999,800 Theravance Biopharma, Inc. (TBPH) shares for $7,798,440 on Aug 7, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Eli Samaha bought 999,800 Theravance Biopharma, Inc. (TBPH) shares for $7,798,440 on Aug 7, 2024
Date Insider Transaction Shares Price Value Filing
Aug 7, 2024 Eli Samaha P Open-market purchase 999,800 held after: 9,511,150 $7.80 $7,798,440 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Eli Samaha sold 172,889 SYNOVUS FINANCIAL CORP (SNV PR E) shares for $4,356,803 on Jun 10, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Eli Samaha sold 172,889 SYNOVUS FINANCIAL CORP (SNV PR E) shares for $4,356,803 on Jun 10, 2024
Date Insider Transaction Shares Price Value Filing
Jun 10, 2024 Eli Samaha S Open-market sale 172,889 held after: 1,293,259 $25.20 $4,356,803 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 25 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 30 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Theravance Biopharma, Inc. TBPH S Open-market sale 5,564 shares $95.5K at $17.17 SEC filing ↗
  2. Theravance Biopharma, Inc. TBPH S Open-market sale 1,400 shares $23.9K at $17.04 SEC filing ↗
  3. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 2,691 shares $20.0K at $7.43 SEC filing ↗
  4. Theravance Biopharma, Inc. TBPH S Open-market sale 37,799 shares $642.6K at $17.00 SEC filing ↗
  5. Theravance Biopharma, Inc. TBPH S Open-market sale 25,027 shares $428.7K at $17.13 SEC filing ↗
  6. Theravance Biopharma, Inc. TBPH S Open-market sale 273,871 shares $4.72M at $17.23 SEC filing ↗
  7. Stagwell Inc STGW A Grant or awardnot a buy/sell decisionreported at zero 22,970 shares $0 at $0.00 SEC filing ↗
  8. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 3,180 shares $20.0K at $6.29 SEC filing ↗
  9. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 4,090 shares $20.0K at $4.89 SEC filing ↗
  10. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 3,552 shares $20.0K at $5.63 SEC filing ↗
  11. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 4,444 shares $20.0K at $4.50 SEC filing ↗
  12. Stagwell Inc STGW A Grant or awardnot a buy/sell decisionreported at zero 30,000 shares $0 at $0.00 SEC filing ↗
  13. Stagwell Inc STGW P Open-market purchase 240,000 shares $1.06M at $4.43 SEC filing ↗
  14. Stagwell Inc STGW P Open-market purchase 425,757 shares $1.82M at $4.27 SEC filing ↗
  15. Stagwell Inc STGW P Open-market purchase 200,903 shares $956.3K at $4.76 SEC filing ↗
  16. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 3,305 shares $20.0K at $6.05 SEC filing ↗
  17. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 3,040 shares $20.0K at $6.58 SEC filing ↗
  18. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 2,849 shares $20.0K at $7.02 SEC filing ↗
  19. Theravance Biopharma, Inc. TBPH P Open-market purchase 999,800 shares $7.80M at $7.80 SEC filing ↗
  20. Stagwell Inc STGW A Grant or awardnot a buy/sell decision 2,933 shares $20.0K at $6.82 SEC filing ↗
  21. Stagwell Inc STGW A Grant or awardnot a buy/sell decisionreported at zero 22,762 shares $0 at $0.00 SEC filing ↗
  22. SYNOVUS FINANCIAL CORP SNV PR E S Open-market sale 172,889 shares $4.36M at $25.20 SEC filing ↗
  23. SYNOVUS FINANCIAL CORP SNV PR E S Open-market sale 20 shares $504 at $25.20 SEC filing ↗
  24. SYNOVUS FINANCIAL CORP SNV PR E S Open-market sale 325 shares $8.2K at $25.24 SEC filing ↗
  25. SYNOVUS FINANCIAL CORP SNV PR E S Open-market sale 6,803 shares $171.6K at $25.22 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Stagwell Inc STGW Class A Common Stock (indirect) 8,156,245 $8.77 $71.5M 4 EDGAR ↗
SYNOVUS FINANCIAL CORP — Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E (indirect) 1,293,259 — — 4 EDGAR ↗
Theravance Biopharma, Inc. — COM (indirect) 9,511,150 — — 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Eli Samaha reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: Stagwell Inc (company-published photograph). Original file page on stagwellglobal.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.